A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the
Safety, Tolerability, and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults and Children
Residing in West Africa